1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 3: 
Outcomes in procedures with versus without hemorrhagic complications
VariableaOverall (n = 827)Without HC (n = 735)With HC (n = 92)P Value (without vs with HC)bType of Hemorrhagic Complications
AP (n = 44)NAP (n = 48)P Value (AP vs NAP)b
New disability127 (15)78 (11)49 (53)<.00112 (27)37 (77)<.001
Transient71 (9)53 (7)18 (20)9 (20)9 (19)
Permanent56 (7)25 (3)31 (34)3 (7)28 (58)
Death6 (1)0 (0)6 (7)<.0011 (2)5 (10)<.207
  • ↵a No. (%).
  • ↵b χ2 or Fisher exact test for cells <5.